600223.SH
Lushang Freda Pharmaceutical Co., Ltd.
SSE · Healthcare · Real Estate - Development · CN
CNY 5.37
−1.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 27.21x
- P/E 2027E
- 22.63x
- P/E 2028E
- 18.93x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.08x
- PEG TTM
- 0.48x
- Price / book
- 1.27x
- Price / sales
- 1.45x
- Price / cash flow
- 14.61x
Enterprise value
- Enterprise value
- CNY 3.3B
- EV / sales
- 0.91x
- EV / EBITDA
- 8.28x
- EV / EBIT
- 12.90x
- Market cap
- CNY 5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026